A study on the efficacy and safety of olmesartan medoxomil and its combination with hydrochlorothiazide compared with an ACE inhibitor and its combination with a calcium channel blocker in patients with stage 2 hypertension

Trial Profile

A study on the efficacy and safety of olmesartan medoxomil and its combination with hydrochlorothiazide compared with an ACE inhibitor and its combination with a calcium channel blocker in patients with stage 2 hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Olmesartan medoxomil/hydrochlorothiazide (Primary) ; Amlodipine; Amlodipine/benazepril; Benazepril; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 17 Jan 2012 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
    • 05 May 2007 Status changed to completed; results data reported at ASH
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top